JHS Sven.Lab.

Market Cap: Micro Cap
Industry: FMCG
ISIN: INE544H01014
NSEID: JHS
BSEID: 532771

INR

10.16

0.04 (0.4%)

BSENSE

Dec 15

BSE+NSE Vol: 66.13 k

{
  "main_header": {
    "sid": 150728,
    "name": "JHS Sven.Lab.",
    "stock_name": "JHS Sven.Lab.",
    "full_name": "JHS Svendgaard Laboratories Ltd",
    "name_url": "stocks-analysis/jhs-svenlab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "10.16",
    "chg": 0.04,
    "chgp": "0.4%",
    "dir": 1,
    "prev_price": "10.12",
    "mcapval": "86.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532771,
    "symbol": "JHS",
    "ind_name": "FMCG",
    "ind_code": 31,
    "indexname": "",
    "isin": "INE544H01014",
    "curr_date": "Dec 15",
    "curr_time": "",
    "bse_nse_vol": "66.13 k",
    "exc_status": "Active",
    "traded_date": "Dec 15, 2025",
    "traded_date_str": "2025 12 15",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jhs-svenlab-150728-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "JHS Svendgaard Laboratories Falls to 52-Week Low Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jhs-svendgaard-laboratories-stock-hits-52-week-low-amidst-continued-underperformance-3758866",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/JHSSvendgaardLa_priceRelatedfactors_3758866.png",
        "date": "2025-12-15 16:00:08",
        "description": "JHS Svendgaard Laboratories has reached a fresh 52-week low, closing near ₹9.9, marking a significant price level that reflects ongoing challenges within the FMCG sector. The stock's recent performance contrasts sharply with broader market trends and highlights persistent pressures on the company’s financial metrics."
      },
      {
        "title": "JHS Svendgaard Laboratories Stock Falls to 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jhs-svendgaard-laboratories-stock-falls-to-52-week-low-amidst-continued-downtrend-3751822",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/JHSSvendgaardLa_priceRelatedfactors_3751822.png",
        "date": "2025-12-08 16:00:10",
        "description": "Shares of JHS Svendgaard Laboratories have declined to a fresh 52-week low, closing near Rs 9.9, marking a significant milestone in the stock's ongoing downward trajectory. This development comes amid a series of consecutive sessions with negative returns and persistent underperformance relative to broader market indices."
      },
      {
        "title": "JHS Sven.Lab. Sees Revision in Market Assessment Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jhs-svenlab-downgraded-to-strong-sell-amid-deteriorating-fundamentals-and-bearish-outlook-3749887",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/JHSSvenLab_mojoScore_3749887.png",
        "date": "2025-12-06 10:10:14",
        "description": "JHS Sven.Lab., a microcap player in the FMCG sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The stock’s recent performance and fundamental indicators highlight a cautious stance among investors as the company navigates a difficult operating environment."
      },
      {
        "title": "Why is JHS Sven.Lab. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-jhs-svenlab-fallingrising-3749399",
        "imagepath": "",
        "date": "2025-12-06 00:44:10",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Extended Downtrend Reflects Investor Concerns</strong></p>\n<p>The stock has been on a downward trajectory for some time, with returns over the past year plunging by 54.9%, starkly contrasting with the Sensex’s 4.83% gain during the same period. This negative trend extends over longer horizons as well, with a five-year return of -48.33% for JHS Svendgaard Laboratories compared to a robust 90.14% rise in the Sensex. Such persistent underperformance signals deep-rooted challenges facing the company or waning investor confidence.</p>\n<p>In the short term, the stock’s performance remains weak. Over the last month, it has declined by 15.36%, while the Sensex advanced by 2.7%. Even in the past week, the stock fell 3.72%, whereas the benchmark index remained virtually flat. This divergence highlight..."
      },
      {
        "title": "JHS Svendgaard Q2 FY26: Persistent Losses Continue Despite Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/jhs-svendgaard-q2-fy26-persistent-losses-continue-despite-revenue-growth-3711904",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JHSSvendgaardLa_quaterlyResult_3711904.png",
        "date": "2025-11-18 09:33:43",
        "description": "JHS Svendgaard Laboratories Ltd., the Himachal Pradesh-based oral care products manufacturer, reported a quarterly loss of ₹0.20 crores in Q2 FY26, marking a sharp reversal from the ₹1.06 crores profit recorded in the previous quarter. Despite achieving revenue growth of 13.21% year-on-year to ₹22.28 crores, the company's inability to convert top-line expansion into profitability continues to plague its financial performance. With a market capitalisation of just ₹102 crores and the stock trading at ₹11.80—down 46.85% over the past year—investor sentiment remains deeply pessimistic towards this micro-cap FMCG player."
      },
      {
        "title": "How has been the historical performance of JHS Sven.Lab.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-jhs-svenlab-3702868",
        "imagepath": "",
        "date": "2025-11-14 23:36:21",
        "description": "Answer:\nThe historical performance of JHS Sven.Lab. shows a fluctuating trend in net sales and profitability over the years, with significant losses in recent periods.\n\nBreakdown:\nJHS Sven.Lab. reported net sales of 92.00 Cr in March 2025, an increase from 70.80 Cr in March 2024, but a decline from 96.21 Cr in March 2023. The total operating income mirrored this trend, reaching 92.00 Cr in March 2025, while total expenditure rose to 96.01 Cr, leading to an operating profit (PBDIT) of -1.13 Cr for the same period. This marked a deterioration from the previous year's operating profit of 3.38 Cr. The company faced a profit before tax of -12.51 Cr in March 2025, worsening from -3.43 Cr in March 2024, and a profit after tax of -19.74 Cr, compared to -4.06 Cr in the prior year. The earnings per share also reflected this decline, showing -2.31 in March 2025. On the balance sheet, total liabilities increased to 197..."
      },
      {
        "title": "How has been the historical performance of JHS Sven.Lab.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-jhs-svenlab-3698866",
        "imagepath": "",
        "date": "2025-11-13 23:14:58",
        "description": "Answer:\nThe historical performance of JHS Sven.Lab. shows a fluctuating trend in net sales and profitability over the years, with significant losses reported in recent periods.\n\nBreakdown:\nJHS Sven.Lab. reported net sales of 92.00 Cr for the year ending March 2025, a notable increase from 70.80 Cr in March 2024, but a decline from 96.21 Cr in March 2023. The total operating income followed a similar pattern, reaching 92.00 Cr in March 2025, up from 70.80 Cr in the previous year. However, the company faced rising raw material costs, which increased to 57.46 Cr in March 2025 from 40.83 Cr in March 2024. Operating profit (PBDIT) was negative at -1.13 Cr in March 2025, down from a positive 3.38 Cr in March 2024, indicating ongoing challenges in managing expenses. The profit before tax also worsened to -12.51 Cr in March 2025 from -3.43 Cr in March 2024, while the profit after tax showed a significant loss of -1..."
      },
      {
        "title": "When is the next results date for JHS Sven.Lab.?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-jhs-svenlab-3693874",
        "imagepath": "",
        "date": "2025-11-12 23:16:23",
        "description": "JHS Sven.Lab. will declare its results on 14 November 2025...."
      },
      {
        "title": "When is the next results date for JHS Sven.Lab.?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-jhs-svenlab-3691051",
        "imagepath": "",
        "date": "2025-11-11 23:17:35",
        "description": "JHS Sven.Lab. will declare its results on 14 November 2025...."
      }
    ],
    "total": 169,
    "sid": "150728",
    "stock_news_url": "https://www.marketsmojo.com/news/jhs-svendgaard-laboratories-150728"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "16-Nov-2025",
      "details": "Newspaper Publication of Financial Results for quarter and half year ended 30 September 2025",
      "source": "BSE"
    },
    {
      "caption": "Financial Results For The Quarter And Half Year Ended 30Th September 2025",
      "datetime": "14-Nov-2025",
      "details": "Financial Results for the Quarter and Half year ended 30th September 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "14-Nov-2025",
      "details": "Financial Results for the quarter and half year ended 30th September 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "JHS Svendgaard Laboratories Ltd has declared <strong>8%</strong> dividend, ex-date: 26 Dec 11",
          "dt": "2011-12-26",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

JHS Svendgaard Laboratories Falls to 52-Week Low Amidst Continued Underperformance

2025-12-15 16:00:08

JHS Svendgaard Laboratories has reached a fresh 52-week low, closing near ₹9.9, marking a significant price level that reflects ongoing challenges within the FMCG sector. The stock's recent performance contrasts sharply with broader market trends and highlights persistent pressures on the company’s financial metrics.

JHS Svendgaard Laboratories Stock Falls to 52-Week Low Amidst Continued Downtrend

2025-12-08 16:00:10

Shares of JHS Svendgaard Laboratories have declined to a fresh 52-week low, closing near Rs 9.9, marking a significant milestone in the stock's ongoing downward trajectory. This development comes amid a series of consecutive sessions with negative returns and persistent underperformance relative to broader market indices.

JHS Sven.Lab. Sees Revision in Market Assessment Amidst Challenging Fundamentals

2025-12-06 10:10:14

JHS Sven.Lab., a microcap player in the FMCG sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The stock’s recent performance and fundamental indicators highlight a cautious stance among investors as the company navigates a difficult operating environment.

Why is JHS Sven.Lab. falling/rising?

2025-12-06 00:44:10

Extended Downtrend Reflects Investor Concerns

The stock has been on a downward trajectory for some time, with returns over the past year plunging by 54.9%, starkly contrasting with the Sensex’s 4.83% gain during the same period. This negative trend extends over longer horizons as well, with a five-year return of -48.33% for JHS Svendgaard Laboratories compared to a robust 90.14% rise in the Sensex. Such persistent underperformance signals deep-rooted challenges facing the company or waning investor confidence.

In the short term, the stock’s performance remains weak. Over the last month, it has declined by 15.36%, while the Sensex advanced by 2.7%. Even in the past week, the stock fell 3.72%, whereas the benchmark index remained virtually flat. This divergence highlight...

JHS Svendgaard Q2 FY26: Persistent Losses Continue Despite Revenue Growth

2025-11-18 09:33:43

JHS Svendgaard Laboratories Ltd., the Himachal Pradesh-based oral care products manufacturer, reported a quarterly loss of ₹0.20 crores in Q2 FY26, marking a sharp reversal from the ₹1.06 crores profit recorded in the previous quarter. Despite achieving revenue growth of 13.21% year-on-year to ₹22.28 crores, the company's inability to convert top-line expansion into profitability continues to plague its financial performance. With a market capitalisation of just ₹102 crores and the stock trading at ₹11.80—down 46.85% over the past year—investor sentiment remains deeply pessimistic towards this micro-cap FMCG player.

How has been the historical performance of JHS Sven.Lab.?

2025-11-14 23:36:21

Answer: The historical performance of JHS Sven.Lab. shows a fluctuating trend in net sales and profitability over the years, with significant losses in recent periods. Breakdown: JHS Sven.Lab. reported net sales of 92.00 Cr in March 2025, an increase from 70.80 Cr in March 2024, but a decline from 96.21 Cr in March 2023. The total operating income mirrored this trend, reaching 92.00 Cr in March 2025, while total expenditure rose to 96.01 Cr, leading to an operating profit (PBDIT) of -1.13 Cr for the same period. This marked a deterioration from the previous year's operating profit of 3.38 Cr. The company faced a profit before tax of -12.51 Cr in March 2025, worsening from -3.43 Cr in March 2024, and a profit after tax of -19.74 Cr, compared to -4.06 Cr in the prior year. The earnings per share also reflected this decline, showing -2.31 in March 2025. On the balance sheet, total liabilities increased to 197...

How has been the historical performance of JHS Sven.Lab.?

2025-11-13 23:14:58

Answer: The historical performance of JHS Sven.Lab. shows a fluctuating trend in net sales and profitability over the years, with significant losses reported in recent periods. Breakdown: JHS Sven.Lab. reported net sales of 92.00 Cr for the year ending March 2025, a notable increase from 70.80 Cr in March 2024, but a decline from 96.21 Cr in March 2023. The total operating income followed a similar pattern, reaching 92.00 Cr in March 2025, up from 70.80 Cr in the previous year. However, the company faced rising raw material costs, which increased to 57.46 Cr in March 2025 from 40.83 Cr in March 2024. Operating profit (PBDIT) was negative at -1.13 Cr in March 2025, down from a positive 3.38 Cr in March 2024, indicating ongoing challenges in managing expenses. The profit before tax also worsened to -12.51 Cr in March 2025 from -3.43 Cr in March 2024, while the profit after tax showed a significant loss of -1...